Bender Robert & Associates’s PHARMACYCLICS INC PCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-27,762
Closed -$7.11M 59
2015
Q1
$7.11M Sell
27,762
-857
-3% -$165K 4.14% 7
2014
Q4
$3.5M Buy
28,619
+85
+0.3% +$10.9K 2.29% 14
2014
Q3
$3.35M Buy
28,534
+85
+0.3% +$9.69K 2.33% 14
2014
Q2
$2.55M Buy
28,449
+23,649
+493% +$2.22M 1.81% 18
2014
Q1
$481 Hold
4,800
0.32% 35
2013
Q4
$508K Sell
4,800
-250
-5% -$30.3K 0.38% 34
2013
Q3
$698K Buy
5,050
+50
+1% +$5.55K 0.55% 31
2013
Q2
$397K Buy
+5,000
New +$409K 0.34% 37

Other funds holding PCYC

Bender Robert & Associates's PCYC Position: Q2 2015 in Review

Bender Robert & Associates sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 27,762 shares — an estimated $7.11M sold.

Bender Robert & Associates first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $7.11M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

  • Bender Robert & Associates reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
  • Bender Robert & Associates sold 27,762 PHARMACYCLICS INC shares in Q2 2015, an estimated $7.11M.
  • Bender Robert & Associates first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
  • Bender Robert & Associates's PHARMACYCLICS INC position peaked at $7.11M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Bender Robert & Associates's 13F filing for Q2 2015, filed 10 Aug 2015.